Cm Management, LLC Cyma Bay Therapeutics, Inc. Transaction History

Cm Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$3.22 - $6.27 $193,200 - $376,200	60,000 Added 60.0%	160,000 $1 Million
Q3 2022 Nov 04, 2022	SELL	$2.77 - $4.25 $304,700 - $467,500	-110,000 Reduced 52.38%	100,000 $350,000
Q2 2022 Aug 08, 2022	BUY	$1.72 - $3.39 $103,200 - $203,400	60,000 Added 40.0%	210,000 $620,000
Q1 2021 May 12, 2021	BUY	$4.23 - $6.55 $634,500 - $982,500	150,000 New	150,000 $681,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.